NCT03790423View on ClinicalTrials.gov

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 3, 2019

Primary Completion Date

November 18, 2019

Study Completion Date

November 18, 2019

Conditions
Breast CancerLung CancerPancreatic CancerOvarian CancerCervix Cancer
Interventions
DRUG

Injection of 18F-ASIS

Each patient will receive one injection of 18F-ASIS (approximately 200 Mbq)

OTHER

PET/CT scan

Following one injection of 18F-ASIS the patients will be PET/CT scanned at 1 hour, 2 hours and 4 hours post-injection

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03790423 - 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer | Biotech Hunter | Biotech Hunter